Deadline: 17-Jul-25
The Pfizer is requesting proposals to support educational programs on the burden of COVID-19 disease in the pediatric patient population with high risk conditions, targeting pediatricians, pediatric infectious disease specialists, and primary care providers who manage high-risk pediatric patients.
These programs should aim to equip these providers with the necessary knowledge and skills to identify, diagnose, and manage COVID-19 effectively amongst the pediatric patients at high risk for developing severe COVID-19 outcomes.
Areas of Interest
- Through this RFP it is their intent to support educational programs for HCPs that address knowledge gaps in identifying pediatric patients at high risk for developing severe COVID-19 outcomes, including hospitalization or death, and are designed to help achieve the following goals:
- Improve identification of pediatric patients with high-risk conditions and their eligibility for COVID-19 treatment.
- Recognize the importance of early COVID-19 intervention/treatment in high-risk pediatric patients.
- Outline COVID-19 complications associated with high-risk conditions and the impact they have on pediatric patients and healthcare systems.
Funding Information
- Individual projects requesting up to $150,000 will be considered.
- Duration: Maximum project length is one year.
Target Audience
- Pediatricians
- Pediatric Infectious Disease Specialists
- Primary Care Providers, including but not limited to, Family Medicine, Internal Medicine, and Urgent Care Providers
Eligibility Criteria
- The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
- Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).
- If the project involves multiple departments within an institution and/or between different institutions/organizations/associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.
- The applicant must be the project/program lead or an authorized designee of such individual (e.g., project/program lead’s grant coordinator).
- The project/program lead must be an employee or contractor of the requesting organization.
- Requesting organization must be legally able to receive award funding directly from Pfizer Inc. They strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Inc. may be subject to rescission.
- For projects offering continuing education credit, the requesting organization must be accredited.
For more information, visit Pfizer.
